HOME › DRUGS › IGOVOMAB
ACTIVE SUBSTANCE / INN

IGOVOMAB

Brand name(s): Indimacis 125
EMA LISTED
WITHDRAWN
Radionuclide Imaging;Ovarian Neoplasms
ACTIVE SUBSTANCE
Igovomab
REGULATORS
EMA
SPONSORS / MAH
CIS bio international
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Indimacis 125CIS bio internationalWithdrawn04/10/1996Radionuclide Imaging;Ovarian Neoplasms

FULL INTELLIGENCE ON IGOVOMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →